Executive cognitive function and cessation of smoking among older smokers

Aging Health

Volumn 5, Issue 1, 2009, Pages 33-37

  Tait, Robert J ^a   Siru, Ranita ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cessation of smoking; Cognitive function; Older adults

Indexed keywords

NICOTINE;

AGE DISTRIBUTION; ALZHEIMER DISEASE; ARTICLE; ATTITUDE TO HEALTH; BEHAVIOR MODIFICATION; BIPOLAR DISORDER; CIGARETTE SMOKING; COGNITION; COGNITIVE DEFECT; COUNSELING; DEMENTIA; ETHNIC DIFFERENCE; HEALTH CARE DELIVERY; HEALTH ECONOMICS; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; INTERVENTION STUDY; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; POPULATION RESEARCH; PREDICTION AND FORECASTING; RISK FACTOR; SCHIZOPHRENIA; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SMOKING HABIT; SOCIAL SUPPORT;

EID: 70249135283     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/1745509X.5.1.33     Document Type: Article

References (53)

1. Brega A, Grigsby J, Kooken R, Hamman R, Baxter J: The impact of executive cognitive functioning on rates of smoking cessation in the San Luis Valley Health and Aging Study. Age Ageing 37, 521-525 (2008).
2. Gostin LO: Global regulatory strategies for tobacco control. JAMA 298, 2057-2059 (2007).
3. Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI: Priorities among effective clinical preventive services: results of a systematic review and analysis. Am. J. Prev. Med. 31, 52-61 (2006).
4. US Department of Health and Human Services: The health consequences of smoking: a report of the Surgeon General. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health (2004).
5. Maguire C, Ryan J, Kelly A, O'Neill D, Coakley D, Walsh J: Do patient age and medical condition influence medical advice to stop smoking? Age Ageing 29, 264-266 (2000).
6. Higgins MW, Enright PL, Kronmal RA et al.: Smoking and lung function in elderly men and women: the Cardiovascular Health Study. JAMA 269, 2741-2748 (1993).
7. Fries JF, Green LW, Levine S: Health promotion and the compression of morbidity. Lancet 1, 481-483 (1989).
8. LaCroix AZ, Lanag J, Scherr P et al.: Smoking and mortality among older men and women in three communities. N. Engl. J. Med. 324, 1619-1625 (1991).
9. Chapman S: Falling prevalence of smoking: how low can we go. Tob. Control 16, 145-147 (2007).
10. White V, Hill D, Siahpush M, Bobevski I: How has the prevalence of cigarette smoking changed among Australian adults? Trends in smoking prevalence between 1980 and 2001. Tob. Control 12, II67-II74 (2003).
11. Husten C, Shelton D, Chrismon J, Lin Y, Mowery P, Powell F: Cigarette smoking and smoking cessation among older adults: United States, 1965-94 Tob. Control 6, 175-80 (1997).
12. Hagmann M: The world in 2050: more crowded, urban and aged. Bull. World Health Organ 79, 482-483 (2001).
13. Kerr S, Watson H, Tolson D, Lough M, Brown M: Smoking after the age of 65 years: a qualitative exploration of older current and former smokers' views on smoking, stopping smoking, and smoking cessation resources and services. Health Soc. Care Community 14, 572-82 (2006).
14. Rimer BK, Orleans CT, Fleisher L et al.: Does tailoring matter? The impact of a tailored guide on ratings and short-term smoking-related outcomes for older smokers. Health Educ. Res. 9, 69-84 (1994).
15. Vetter NJ, Ford D: Smoking prevention among people aged 60 and over: a randomized controlled trial. Age Ageing 19, 164-168 (1990).
16. Morgan GD, Noll EL, Orleans CT, Rimer BK, Amfoh K, Bonney G: Reaching midlife and older smokers: tailored interventions for routine medical care. Prev. Med. 25, 346-354 (1996).
17. Orleans C, Resch N, Noll E et al.: Use of transdermal nicotine in a state-level prescription plan for the elderly. A first look at 'real-world' patch users. JAMA 271, 601-607 (1994).
18. Tait RJ, Hulse GK, Waterreus et al.: Effectiveness of a smoking cessation intervention in older adults. Addiction 102, 148-155 (2007)
19. Campbell IA, Prescott RJ, Tjeder-Burton SM: Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study. Respir. Med. 90, 47-51 (1996).
20. Steinberg MB, Akincigil A, Delnevo CD, Crystal S, Carson JL: Gender and age disparities for smoking-cessation treatment. Am. J. Prev. Med. 30, 405-12 (2006).
21. Ossip-Klein DJ, McIncosh S, Utman C, Burton K, Spada J, Guido J: Smokers ages 50+: who gets physician advice to quit? Prev. Med. 31, 364-369 (2000).
22. Brown D, Croft JB, Schenck AP, Malarcher AM, Giles WH, Simpson RJ: Inpatient smoking-cessation counseling and all-cause mortality among the elderly. Am. J. Prev. Med. 26, 112-118 (2004).
23. Wilson K, Gibson N, Willan A, Cook D: Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch. Intern. Med. 160, 939-44 (2000).
24. Youg H-H, Borland R, Siahpush M: Quitting-related beliefs, intentions, and motivations of older smokers in four countries: findings from the international tobacco control policy evaluation survey. Addict. Behav. 30, 777-788 (2005).
25. Fuster J: Executive frontal functions. Exp. Brain Res. 133, 66-70 (2000).
26. Kahokehr A, Siegert RJ, Weatherall M: The frequency of executive cognitive impairment in elderly rehabilitation inpatients. J. Geriatr. Psychiatry Neurol. 17, 68-72 (2004).
27. Luria AR: Higher Cortical Function in Man, 2nd Edition. Basic Books, NY, USA (1980).
28. Kramer AM, Kowalsky JC, Lin M, Grigsby J, Hughes R, Steiner JF: Executive cognitive abilities and functional status among community-dwelling older persons in the San Luis Valley Health and Aging Study. J. Am. Geriatr. Soc. 46, 726-34 (1998).
29. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198 (1975).
30. Ruchinskas RA, Curyto KJ: Cognitive screening in geriatric rehabilitation. Rehabil. Psychol. 48, 14-22 (2003).
31. Anstey KJ, von Sanden C, Salim A, O'Kearney R: Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am. J. Epidemiol. 166, 367-378 (2007).
32. Almeida O, Hulse G, Lawrence D, Flicker L: Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case - control and cohort studies. Addiction 97, 15-28 (2002).
33. Williams JM, Ziedonis D: Addressing tobacco among individuals with a mental illness or an addiction. Addict. Behav. 29, 1067-1083 (2004).
34. Quraishi S, Frangou S: Neuropsychology of bipolar disorder: a review. J. Affect. Disord. 72, 209-226 (2002).
35. Johnson-Selfridge M, Zalewski C: Moderator variables of executive functioning in schizophrenia: meta-analytic findings. Schizophr. Bull. 27, 305-316 (2001).
36. Martinez-Aran A, Penades R, Vieta E it al.: Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome. Psychother. Psychosgm. 71, 39-46 (2002).
37. Dani JA, Harris RA: Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat. Neurosci. 8, 1465-1470 (2005).
38. Breslau N, Klein DF: Smoking and panic attacks: an epidemiologic investigation. Arch. Gen. Psychiatry 56, 1141-1147 (1999).
39. MMWR: Efforts to quit smoking among persons with a history of alcohol problems: Iowa, Kansas and Nebraska 1995-1996. MMWR: Morb. Mortal. Wkly Rep. 46, 1144-1148 (1997).
40. Niaura R, Britt DM, Borrelli B, Shadel WG, Abrams DB, Goldstein MG: History and symptoms of depression among smokers during a self-initiated quit attempt. Nicotine Tob. Res. 1, 251 (1999).
41. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA: Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 61, 1107-1115 (2004).
42. Elisha D, Castle D, Hocking B: Reducing social isolation in people with mental illness: the role of the psychiatrist. Australas. Psychiatry 14, 281-284 (2006).
43. Lawrence D, Holman CD, Jablenski A, Hobbs MS: Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980-1998. Br. J. Psychiatry 182, 31-36 (2003).
44. Himelhoch S, Daumit G: To whom do psychiatrists offer smoking-cessation counseling? Am. J. Psychiatry 160, 2228-2230 (2003).
45. Price J, Ambrosetti L, Sidani J, Price J: Psychiatrists' smoking cessation activities with Ohio community mental health center patients. Community Ment. Health J. 43, 251-266 (2007).
46. Glynn SM, Sussman S: Why patients smoke. Hosp. Community Psychiatry 41, 1027 (1990).
47. Van Dongen C: Smoking and persistent mental illness: an exploratory study. J. Psychosocl. Nurs. Ment. Health Serv. 37, 26-34 (1999).
48. Bellack AS, DiClemente CC: Treating substance abuse among patients with schizophrenia. Psychiatr. Serv. 50, 75-80 (1999).
49. Royall DR, Espino DV, Polk MJ, Palmer RF, Markides KS: Prevalence and patterns of executive impairment in community dwelling. Mexican Americans: results from the Hispanic EPESE Study. Int. J. Geriatr. Psychiatry 19, 926-934 (2004).
50. Prochaska JO, DiClemente CC: Stages and processes of self-change of smoking: towards an integrative model of change. J. Consult. Clin. Psychol. 51, 390-395 (1983).
51. Prochaska JO, DiClemente CC, Norcross JC: In search of how people change. Applications to addictive behaviors. Am. Psychol. 47, 1102-14 (1992).
52. Blume AW, Schmaling KB, Marlatt GA: Memory, executive cognitive function, and readiness to change drinking behavior. Addict. Behav. 30, 301-314 (2005).
53. Cataldo JK: Smoking and aging: clinical implications part I: health and consequence. J. Gerontol. Nurs. 29, 15-20 (2003).